Citius Pharmaceuticals, based in Cranford, NJ, specializes in critical care products, particularly in oncology and anti-infectives. Its key products include LYMPHIR, Mino-Lok, Halo-Lido, Mino-Wrap, and NoveCite.
Citius Pharmaceuticals (CTXR) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Citius Pharmaceuticals's actual EPS was -$1.27, missing the estimate of -$0.04 per share, resulting in a -3457.42% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
